Eli Lilly has announced an agreement with the Bill & Melinda Gates Foundation for potential supply of its experimental antibody treatments for COVID-19 to low and middle-income countries.
As part of the deal, Lilly said make antibody therapies available to lower-income countries prior to April 2021, but did not elaborate on the number of doses.
Countering Misinformation & Disinformation: Practical Training for Organizations
Practical skills to detect, verify, and respond across an evolving information landscape